- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Vegan Diets Can Improve HbA1c, Body Weight in Overweight or Type 2 Diabetes
May 06, 2022
Data from a study presented at the European Congress on Obesity details the effects of adherence to a vegan diet on cardiometabolic health using data obtained from randomized controlled trials assessing the effects of vegan diets as an intervention.
Reducing Sedentary Time By An Hour Per Day Can Provide Health Benefits in Metabolic Syndrome
May 05, 2022
A 3-month trial found reducing sedentary time by just an hour per day was enough to produce statistically significant changes in biomarkers for cardiovascular risk among patients with metabolic syndrome.
iLet Bionic Pancreas Shows Promise in Pivotal Trial
May 04, 2022
Data from a pivotal trial presented at ATTD 2022 demonstrate the use of the iLet Bionic Pancreas was associated with significant improvements in HbA1c and TIR among a diverse study population of adults and children with type 1 diabetes compared with standard care.
Study Details Diabetes App Features Associated with Improving Glycemic Control
May 03, 2022
A review of data presented at ATTD 2022 dissects what features within smartphone applications created to improve diabetes management actually contribute to improved glycemic control.
SGLT2 Inhibitor, GLP-1 Receptor Agonist Prescribing Increased Sharply Since 2015
May 02, 2022
New data suggests the number of prescriptions for SGLT2 inhibitors in the US has doubled since 2015 with prescriptions for GLP-1 receptor agonists tripling during the same time period.
Low Carb Diet Can Improve Glycemic Control, Lipid Profile in Adolescents with Type 1 Diabetes
April 29, 2022
An RCT comparing a low carbohydrate diet against a Mediterranean diet in adolescents with T1D provides insight into the effects of both dietary approaches on glycemic control among these patients.
Diabetes Dialogue: April 2022 Edition
April 28, 2022
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of the FDA's approval of semaglutide 2.0 mg, the use of novel glycemic control metrics, and a preview of ATTD 2022.
Initial eGFR Dips Common with SGLT2 Inhibitors, Not Typically Associated with Negative Outcomes
April 25, 2022
An analysis of the DAPA-HF trial provides insight into the occurrence of eGFR dips in the first 14 days following initiation of therapy with an SGLT2 inhibitor and their association with long-term outcomes.
Endocrine Month in Review: April 2022
April 23, 2022
Our endocrine month in review spotlights the most popular articles from the past month. This month's top articles include a multipart video series, new diabetes, information on osteoporosis, and more!
Unmet Needs in Diabetes Management
April 21, 2022
Dr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.